Molecule to Market is proudly sponsored by Bora Pharmaceuticals - The premium CDMO partner

Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 250

    M2M Monitor Special – 2026

    Raman Sehgal

    / Molecule to Market

    M2M’s 250th episode! Our host Raman Sehgal summarises the highlights from the 2025 guest interviews and provides key insights for 2026.

  • Episode 249

    The master building CEO leading Codis

    Nick Fortin

    / Codis

    Nick Fortin, CEO of Codis talks about his leadership in transforming Particle Dynamis into Codis and managing multiple stakeholders.

  • Episode 248

    From R&D to CRO CEO

    Dr Fozia Saleem

    / Magnitude Biosciences

    Dr Fozia Saleem, CEO of Magnitude Biosciences talks about her experience in R&D, fundraising and growing a university spin out post COVID.

  • Episode 247

    M&A Roundtable Q4 2025 – Reflections and Predictions

    Andrew Gigax, Jason Foss, Jennifer Chadwick & Sabina Ouimet-Storrs

    / William Blair, Bora Pharmaceuticals, Jennifer Chadwick Consulting & GHO Capital Partners

    Hear experts talk about their reflections and predictions from Q4 2025 and how it will shape the pharmaceutical and biotechnology ecosystem.

  • Episode 246

    From Pharma to CRO entrepreneur

    Jean-François Brepson

    / PathoQuest

    Jean-François Brepson, CEO at PathoQuest shares his deep experience as a dedicated leader in biotechnology and pharmaceuticals.

  • Episode 245

    The CEO leading Ensera’s evolution

    Jason Anderson

    / Ensera

    Jason Anderson, CEO of Ensera (formerly SteriPack) discusses about the pharmaceutical and biotechnology supply chain.

  • Episode 244

    CPHI 2025 wrap-up

    Raman Sehgal

    / Molecule to Market Host

    Our host Raman Sehgal discusses the themes and vibe of CPHI 2025 in Frankfurt.

  • Episode 243

    20 years of CPHI – Veterans Guide

    Veterans

    /

    Raman gathers great insider tips from a wise group of veterans of CPHI who have two decades of experience.

  • Episode 242

    Themes from PBOA Conference 2025

    Gil Roth

    / Pharma & Biopharma Outsourcing Association (PBOA)

    Gil Roth, President, at Pharma & Biopharma Outsourcing Association (PBOA) discusses the themes from this year’s PBOA Conference.

  • Episode 241

    The understated CDMO CCO

    Jean-Baptiste

    / Agnus

    JB Agnus, CCO of Bora Pharmaceuticals joins our podcast discussing about the pharmaceutical and biotechnology supply chain.

  • Load more